Biodesy Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Biodesy Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10542
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biodesy Inc (Biodesy) is a drug discovery company that develops and offers products for detecting conformational change in proteins and other biological molecules. The company provides products such as delta system, delta assay and screening kits, and delta software, among others. It also develops and provides technology based on a phenomenon called second-harmonic generation that can monitor structural change within a protein in real time. Biodesy’s technology is used to measure functional activation in a protein, finds and validates compounds, and others. The company also provides compounds to treat Alzheimer’s and Parkinson’s diseases, cancers, cardiovascular diseases, and others. Biodesy is headquartered in San Francisco, California, the US.

Biodesy Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biodesy Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biodesy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Biodesy Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Biodesy Raises USD20 Million in Series C Venture Financing 10
Biodesy Raises USD10 Million in Series B Financing 11
Biodesy Raises US$15 Million In Series A Financing 12
Partnerships 13
Biodesy Enters into Research Agreement with Amgen 13
Biodesy Inc – Key Competitors 14
Biodesy Inc – Key Employees 15
Biodesy Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Jun 29, 2017: Biodesy Appoints Dominique Bridon as Chief Executive Officer 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Biodesy Inc, Pharmaceuticals & Healthcare, Key Facts 2
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biodesy Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biodesy Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Biodesy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Biodesy Raises USD20 Million in Series C Venture Financing 10
Biodesy Raises USD10 Million in Series B Financing 11
Biodesy Raises US$15 Million In Series A Financing 12
Biodesy Enters into Research Agreement with Amgen 13
Biodesy Inc, Key Competitors 14
Biodesy Inc, Key Employees 15

List of Figures
Biodesy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biodesy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biodesy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Biodesy Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Simon Property Group Inc (SPG):企業の財務・戦略的SWOT分析
    Simon Property Group Inc (SPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • InfuSystem Holdings Inc (INFU):企業の財務・戦略的SWOT分析
    Summary InfuSystem Holdings Inc (InfuSystem) is a provider of infusion pumps and related services. The company provides ambulatory infusion pumps and associated clinical services. Its patient services comprise infucare help hotline, infuease, education, and pain management. InfuSystem offers pumps a …
  • POSCO:企業の戦略・SWOT・財務情報
    POSCO - Strategy, SWOT and Corporate Finance Report Summary POSCO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Medical Facilities Corp (DR):製薬・医療:M&Aディール及び事業提携情報
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • Outlook Therapeutics Inc (ONSIU):企業の財務・戦略的SWOT分析
    Summary Outlook Therapeutics Inc (Outlook Therapeutics), formerly Oncobiologics Inc, is a biopharmaceutical company that develops, manufactures and commercializes biosimilar products in the areas of ophthalmology. The company is investigating its lead product candidate, ONS-5010 an ophthalmic formul …
  • MYnd Analytics Inc (MYND):医療機器:M&Aディール及び事業提携情報
    Summary MYnd Analytics Inc (MYnd Analytics), formerly CNS Response Inc, is a predictive analytics company. The company develops a decision support tool that assists physicians in the provision of personalized medication for individual patients suffering from mental health issues. It provides Psychia …
  • Catholic University of Louvain:製薬・医療:M&Aディール及び事業提携情報
    Summary Catholic University of Louvain (UCL) is an educational service provider that offers undergraduate, post graduate and certificate programs. The university offers educational programs in the areas of science, agricultural sciences and biological engineering, motor sciences, dental sciences, en …
  • Hertz Global Holdings Inc:企業の戦略・SWOT・財務情報
    Hertz Global Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Hertz Global Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Advanced Metallurgical Group NV:企業の戦略・SWOT・財務情報
    Advanced Metallurgical Group NV - Strategy, SWOT and Corporate Finance Report Summary Advanced Metallurgical Group NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bajaj Corp Limited:企業の戦略・SWOT・財務情報
    Bajaj Corp Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Corp Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Royal Mail plc (RMG):企業の財務・戦略的SWOT分析
    Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cutera Inc (CUTR):企業の財務・戦略的SWOT分析
    Cutera Inc (CUTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Reliance Infrastructure Ltd (RELINFRA)-エネルギー分野:企業M&A・提携分析
    Summary Reliance Infrastructure Limited (RIL) is an utility company that generates, transmits, distributes, purchases and trades electricity in India. It provides electricity to power to residential, industrial, commercial and other consumers. The company offers value-added services in construction, …
  • Schneider Electric (Australia) Pty Ltd:企業の戦略的SWOT分析
    Schneider Electric (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • NXP Semiconductors NV (NXPI):企業の財務・戦略的SWOT分析
    NXP Semiconductors NV (NXPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The Real Good Food Company plc:企業の戦略・SWOT・財務分析
    The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report Summary The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Phu Hung Securities Company:企業の戦略的SWOT分析
    Phu Hung Securities Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • KGHM Polska Miedz SA:企業の戦略・SWOT・財務情報
    KGHM Polska Miedz SA - Strategy, SWOT and Corporate Finance Report Summary KGHM Polska Miedz SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lee’s Pharmaceutical Holdings Ltd (950):企業の財務・戦略的SWOT分析
    Summary Lee's Pharmaceutical Holdings Ltd (Lee's Pharmaceutical) is a bio pharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematolog …
  • Occidental Petroleum Corporation (OXY)-エネルギー分野:企業M&A・提携分析
    Summary Occidental Petroleum Corporation (Occidental) is an oil and gas exploration and production company with integrated assets. The company is active in upstream exploration and production; midstream and marketing; and chemicals business. The oil and gas business explores for, develops and produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆